Cannabinoids are chemical compounds found naturally within the Cannabis sativa plant. At least 32 compounds are known to exist within the plant. Therapeutic benefits are established for a number of these compounds, but many are not available in the quantity or purity level medicinal chemists require to fully study clinical efficacy.
More than 300 clinical studies are underway globally, most involving just two of the components, dronabinol (THC) and cannabidiol (CBD). To help clinicians and drug development companies advance potentially life-changing drug development, Noramco is expanding its Cannabinoids offering, producing products through a combination of synthetic and biosynthetic routes.